2022 Q1 Form 10-Q Financial Statement

#000156459022020441 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $191.0K $176.6K
YoY Change 8.15% -48.24%
Cost Of Revenue $774.8K $480.0K
YoY Change 61.42% -5.88%
Gross Profit -$979.0K $5.370M
YoY Change -118.23% -3258.82%
Gross Profit Margin -512.55% 3040.63%
Selling, General & Admin $4.443M $99.77K
YoY Change 4353.45% 24.36%
% of Gross Profit 1.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.094K $1.696K
YoY Change 82.43% -70.82%
% of Gross Profit 0.03%
Operating Expenses $4.446M $1.904M
YoY Change 133.49% 111.16%
Operating Profit -$5.425M -$1.728M
YoY Change 214.02% 208.17%
Interest Expense -$598.2K $464.00
YoY Change -129022.41% -93.27%
% of Operating Profit
Other Income/Expense, Net $4.370K
YoY Change
Pretax Income -$6.019M $4.552M
YoY Change -232.24% -902.05%
Income Tax $0.00 $3.484K
% Of Pretax Income 0.08%
Net Earnings -$5.728M $4.376M
YoY Change -230.88% -894.14%
Net Earnings / Revenue -2998.92% 2478.05%
Basic Earnings Per Share -$0.44 $0.87
Diluted Earnings Per Share -$438.6K $0.80
COMMON SHARES
Basic Shares Outstanding 13.06M 5.047M
Diluted Shares Outstanding 13.06M 5.439M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.69M $17.80M
YoY Change 44.33% 2211.69%
Cash & Equivalents $24.54M $17.80M
Short-Term Investments $1.154M
Other Short-Term Assets $1.449M $210.0K
YoY Change 589.92% 75.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.74M $18.17M
YoY Change 63.65% 1330.77%
LONG-TERM ASSETS
Property, Plant & Equipment $352.2K $140.0K
YoY Change 151.59% -41.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.663M $1.789M
YoY Change 216.49% 17.72%
Other Assets $23.98M $10.98K
YoY Change 218258.16% 9.84%
Total Long-Term Assets $30.00M $8.269M
YoY Change 262.79% 365.85%
TOTAL ASSETS
Total Short-Term Assets $29.74M $18.17M
Total Long-Term Assets $30.00M $8.269M
Total Assets $59.74M $26.44M
YoY Change 125.93% 768.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $373.8K $230.0K
YoY Change 62.52% 130.0%
Accrued Expenses $90.07K $80.00K
YoY Change 12.59% -66.67%
Deferred Revenue
YoY Change
Short-Term Debt $57.34K $38.05K
YoY Change 50.7% 9.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $848.4K $620.0K
YoY Change 36.84% -1.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $190.0K
YoY Change -100.0%
Other Long-Term Liabilities $248.5K $70.00K
YoY Change 254.97%
Total Long-Term Liabilities $248.5K $260.0K
YoY Change -4.43% 77.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $848.4K $620.0K
Total Long-Term Liabilities $248.5K $260.0K
Total Liabilities $1.097M $1.060M
YoY Change 3.48% 68.25%
SHAREHOLDERS EQUITY
Retained Earnings -$19.51M
YoY Change
Common Stock $78.19M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.68M $25.38M
YoY Change
Total Liabilities & Shareholders Equity $59.74M $26.44M
YoY Change 125.93% 769.74%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$5.728M $4.376M
YoY Change -230.88% -894.14%
Depreciation, Depletion And Amortization $3.094K $1.696K
YoY Change 82.43% -70.82%
Cash From Operating Activities -$528.3K $4.971M
YoY Change -110.63% -1648.12%
INVESTING ACTIVITIES
Capital Expenditures $7.119M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$7.437M -$1.780M
YoY Change 317.81% 836.84%
Cash From Investing Activities -$7.437M -$7.454M
YoY Change -0.22% 3780.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -57.34K 8.733M
YoY Change -100.66% 3957.46%
NET CHANGE
Cash From Operating Activities -528.3K 4.971M
Cash From Investing Activities -7.437M -7.454M
Cash From Financing Activities -57.34K 8.733M
Net Change In Cash -8.023M 6.250M
YoY Change -228.36% -2197.82%
FREE CASH FLOW
Cash From Operating Activities -$528.3K $4.971M
Capital Expenditures $7.119M
Free Cash Flow -$7.647M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 lmfa Reverse Stock Split Percentage Of Issued Common Stock
ReverseStockSplitPercentageOfIssuedCommonStock
0.2
CY2020Q2 lmfa Reverse Stock Split Percentage Of Issued Common Stock
ReverseStockSplitPercentageOfIssuedCommonStock
0.1
CY2020Q2 lmfa Reverse Stock Split Percentage Of Outstanding Common Stock
ReverseStockSplitPercentageOfOutstandingCommonStock
0.5
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2021Q2 lmfa Reverse Stock Split Percentage Of Issued Common Stock
ReverseStockSplitPercentageOfIssuedCommonStock
1
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M9D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2022Q1 lmfa Share Based Compensation Arrangement By Share Based Payment Award Options Adjustments In Period Adjustment
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentsInPeriodAdjustment
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2022Q1 lmfa Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1 lmfa Share Based Compensation Arrangements By Share Based Payment Award Options Adjustments In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentsInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1 lmfa Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2021Q1 lmfa Share Based Compensation Arrangement By Share Based Payment Award Options Adjustments In Period Adjustment
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentsInPeriodAdjustment
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q1 lmfa Share Based Compensation Arrangements By Share Based Payment Award Options Adjustments In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentsInPeriodWeightedAverageExercisePrice
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1973413
CY2021Q4 lmfa Convertible Debt Securities Current
ConvertibleDebtSecuritiesCurrent
539351
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2132051
CY2021Q4 us-gaap Debt Securities Current
DebtSecuritiesCurrent
2000000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1251852
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
143822
CY2022Q1 lmfa Digital Assets Net Current
DigitalAssetsNetCurrent
504366
CY2021Q4 us-gaap Investments In And Advances To Affiliates Balance Principal Amount
InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount
4676130
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59736098
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62103941
CY2021Q1 lmfa Interest On Delinquent Association Fees
InterestOnDelinquentAssociationFees
77444
CY2022Q1 lmfa Recoveries On Collection Of Assessments In Excess Of Cost
RecoveriesOnCollectionOfAssessmentsInExcessOfCost
17365
CY2022Q1 lmfa Deposit On Mining Equipment Noncurrent
DepositOnMiningEquipmentNoncurrent
23893672
CY2021Q4 lmfa Deposit On Mining Equipment Noncurrent
DepositOnMiningEquipmentNoncurrent
16775100
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10726
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
23593309
CY2021Q4 us-gaap Assets
Assets
62103941
CY2022Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
57344
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
114688
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
373800
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
121220
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
68002
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
326178
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1725
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
848430
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1093734
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248475
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
248475
CY2022Q1 us-gaap Liabilities
Liabilities
1096905
CY2021Q4 us-gaap Liabilities
Liabilities
1093734
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13091883
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13091883
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13017943
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13017943
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
13092
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
13018
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
78173269
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74525106
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19505057
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13777006
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
58681304
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
60761118
CY2022Q1 us-gaap Minority Interest
MinorityInterest
-42111
CY2021Q4 us-gaap Minority Interest
MinorityInterest
249089
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58639193
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61010207
CY2022Q1 lmfa Real Estate Management And Disposal
RealEstateManagementAndDisposal
31481
CY2022Q1 lmfa Depreciation And Amortization Adjustment
DepreciationAndAmortizationAdjustment
3094
CY2021Q1 us-gaap Profit Loss
ProfitLoss
4548299
CY2021Q1 lmfa Depreciation And Amortization Adjustment
DepreciationAndAmortizationAdjustment
1696
CY2022Q1 lmfa Collection Cost
CollectionCost
-3820
CY2021Q1 lmfa Collection Cost
CollectionCost
2048
CY2022Q1 lmfa Realized Gain On Securities
RealizedGainOnSecurities
-395181
CY2021Q1 lmfa Realized Gain On Securities
RealizedGainOnSecurities
5671464
CY2022Q1 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
288320
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
130
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-986399
CY2022Q1 lmfa Digital Assets Other Income
DigitalAssetsOtherIncome
4366
CY2022Q1 lmfa Interest Income
InterestIncome
98370
CY2022Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1375
CY2021Q1 lmfa Income Tax Expense
IncomeTaxExpense
3484
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-291200
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3094
CY2022Q1 lmfa Underwriting Fees And Other Revenues
UnderwritingFeesAndOtherRevenues
16791
CY2021Q1 lmfa Underwriting Fees And Other Revenues
UnderwritingFeesAndOtherRevenues
22703
CY2022Q1 lmfa Rental Revenue
RentalRevenue
38872
CY2021Q1 lmfa Rental Revenue
RentalRevenue
31917
CY2022Q1 us-gaap Revenues
Revenues
191004
CY2021Q1 us-gaap Revenues
Revenues
176608
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
774820
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
482943
CY2022Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
160
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
171866
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5728051
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4376433
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13060736
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5439398
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6019251
CY2021Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
12784
CY2022Q1 lmfa Digital Assets Other Income
DigitalAssetsOtherIncome
4366
CY2021Q1 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
43623
CY2022Q1 lmfa Unrealized Gain Loss On Convertible Debt Securities
UnrealizedGainLossOnConvertibleDebtSecurities
288320
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
595392
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-326178
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3484
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
143822
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-528304
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4970943
CY2021Q1 lmfa Proceeds From Underwriting And Origination Fees
ProceedsFromUnderwritingAndOriginationFees
-62432
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1696
CY2022Q1 lmfa Right To Use Asset Expense
RightToUseAssetExpense
23343
CY2021Q1 lmfa Right To Use Asset Expense
RightToUseAssetExpense
25808
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
329500
CY2022Q1 lmfa Stock Option Expense1
StockOptionExpense1
3318737
CY2022Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
96657
CY2022Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-986399
CY2022Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-395181
CY2021Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
5671464
CY2022Q1 lmfa Proceeds From Securities
ProceedsFromSecurities
1428050
CY2021Q1 lmfa Proceeds From Securities
ProceedsFromSecurities
21218918
CY2021Q1 lmfa Investment In Convertible Note Receivable Converted Into Marketable Security
InvestmentInConvertibleNoteReceivableConvertedIntoMarketableSecurity
15547454
CY2022Q1 lmfa Digital Assets Income
DigitalAssetsIncome
500000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-136430
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
252580
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
200749
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
30242
CY2022Q1 lmfa Payments To Deposits For Mining Equipment
PaymentsToDepositsForMiningEquipment
7118572
CY2021Q1 lmfa Investment In Convertible Note Receivable
InvestmentInConvertibleNoteReceivable
1666500
CY2021Q1 lmfa Loan To Purchase Securities
LoanToPurchaseSecurities
1784250
CY2022Q1 lmfa Investment In Note Receivable Related Party
InvestmentInNoteReceivableRelatedParty
310000
CY2021Q1 lmfa Repayment Of Loan To Purchase Securities
RepaymentOfLoanToPurchaseSecurities
1784250
CY2021Q1 lmfa Payments To Acquire Investment In Unconsolidated Affiliate
PaymentsToAcquireInvestmentInUnconsolidatedAffiliate
5738000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7437070
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7453746
CY2022Q1 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
57344
CY2021Q1 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
468061
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9544623
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57344
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8022718
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32559185
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11552943
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24536467
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17803015
CY2022Q1 lmfa Right Of Use Assets And Operating Lease Obligation Recognized
RightOfUseAssetsAndOperatingLeaseObligationRecognized
300787
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
470000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11468308
CY2021Q1 lmfa Stock Issued For Warrants Exercised
StockIssuedForWarrantsExercised
9544623
CY2021Q1 us-gaap Profit Loss
ProfitLoss
4548299
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25561230
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61010207
CY2022Q1 lmfa Share Based Compensation Employees
ShareBasedCompensationEmployees
329500
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3318737
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6019251
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58639193
CY2022Q1 lmfa Number Of Subsidiaries Created
NumberOfSubsidiariesCreated
2
CY2022Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors On April 21, 2021, our Board of Directors approved a one-for-five reverse split of the Company’s common stock. As a result, on May 7, 2021, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-five (1:5) reverse split of its outstanding common stock, which resulted in a decrease in outstanding common stock to 5,414,296 shares.
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5414296
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5414296
CY2022Q1 lmfa Digital Assets Net Current
DigitalAssetsNetCurrent
504366
CY2022Q1 us-gaap Notes Payable
NotesPayable
57344
CY2021Q4 us-gaap Notes Payable
NotesPayable
114688
CY2022Q1 lmfa Deferred Tax Assets Valuation Allowance Used
DeferredTaxAssetsValuationAllowanceUsed
4677000
CY2021Q4 lmfa Deferred Tax Assets Valuation Allowance Used
DeferredTaxAssetsValuationAllowanceUsed
3246000
CY2022Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-361715
CY2021Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
911648
CY2022Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-48102
CY2021Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
188624
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-409817
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1100272
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1021132
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8214
CY2022Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1430949
CY2021Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1105002
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3484
CY2022Q1 lmfa Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
0.238
CY2021Q1 lmfa Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
0.243
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1432139
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.238
CY2021Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1107447
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.243
CY2022Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1190
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000
CY2021Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1039
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000
CY2022Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1430949
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.238
CY2021Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1105002
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.243
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
216284
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4860342
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3507790
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4677416
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3246467
CY2022Q1 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
1400000
CY2022Q1 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense
1400000
CY2021Q1 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-1100000
CY2021Q1 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense
1100000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59969
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
337413
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59969
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90072
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
68002
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3484
CY2022Q1 lmfa Deferred Tax Liabilities Assets Deferred Vendor Stock Compensation
DeferredTaxLiabilitiesAssetsDeferredVendorStockCompensation
-182926
CY2021Q4 lmfa Deferred Tax Liabilities Assets Deferred Vendor Stock Compensation
DeferredTaxLiabilitiesAssetsDeferredVendorStockCompensation
-261323
CY2022Q1 lmfa Deferred Income Tax Liabilities Assets
DeferredIncomeTaxLiabilitiesAssets
-182926
CY2021Q4 lmfa Deferred Income Tax Liabilities Assets
DeferredIncomeTaxLiabilitiesAssets
-261323
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2511217
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2101401
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1459575
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
669959
CY2022Q1 lmfa Deferred Tax Assets Tax Step Up In Basis Purchase Of Noncontrolling Interest
DeferredTaxAssetsTaxStepUpInBasisPurchaseOfNoncontrollingInterest
41439
CY2021Q4 lmfa Deferred Tax Assets Tax Step Up In Basis Purchase Of Noncontrolling Interest
DeferredTaxAssetsTaxStepUpInBasisPurchaseOfNoncontrollingInterest
42529
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
16539
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
16539
CY2022Q1 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
382407
CY2022Q1 lmfa Adjustments To Right Of Use Of Assets And Lease Liabilities
AdjustmentsToRightOfUseOfAssetsAndLeaseLiabilities
300787
CY2022Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.075
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
23400
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
24900
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
337413
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248475
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
338547
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
68002
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0749
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0655
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
30242
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
24971
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7702441
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.00
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2718012
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.20
CY2021Q1 lmfa Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
2326112
CY2022Q1 lmfa Right Of Use Assets And Operating Lease Obligation Recognized
RightOfUseAssetsAndOperatingLeaseObligationRecognized
300787
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
68328
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
90823
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
103805
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
75591
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
338547
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3956827
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.22
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3860
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3956827
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.22
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
302.55
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3760
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
293.95
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
320.00
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3318000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
13500000
CY2021Q1 lmfa Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
4.08
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7702441
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.00
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
391900
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.35
CY2022Q1 lmfa Debt Instrument Amount Funded For Transaction
DebtInstrumentAmountFundedForTransaction
1666667
CY2022Q1 lmfa Part Of Transaction Purchased Amount
PartOfTransactionPurchasedAmount
3333333
CY2021Q1 lmfa Gain Loss On Loan Agreement
GainLossOnLoanAgreement
5700000
CY2021Q1 lmfa Amount Of Loans Receivables Acquired
AmountOfLoansReceivablesAcquired
18200000
CY2021Q1 lmfa Cost Associated With Acquisition Of Receivables Loan
CostAssociatedWithAcquisitionOfReceivablesLoan
15500000
CY2021Q1 lmfa Proceeds From Sale Of Own Shares
ProceedsFromSaleOfOwnShares
32600000
CY2021Q1 lmfa Provision For Investor
ProvisionForInvestor
11300000
CY2021Q1 lmfa Gain Loss On Loan Agreement
GainLossOnLoanAgreement
5700000
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2132051
CY2022Q1 lmfa Available For Sale Securities Cost Of Shares Sold
AvailableForSaleSecuritiesCostOfSharesSold
-1823231
CY2022Q1 lmfa Available For Sale Debt Securities Accumulated Gross Unrealized Gain Loss
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainLoss
130
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
308950
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4766349
CY2021Q4 lmfa Available For Sale Securities Cost Of Shares Sold
AvailableForSaleSecuritiesCostOfSharesSold
-1246708
CY2021Q4 lmfa Available For Sale Debt Securities Accumulated Gross Unrealized Gain Loss
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainLoss
-1387590
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2132051
CY2021Q4 lmfa Payments To Deposits For Mining Equipment
PaymentsToDepositsForMiningEquipment
7100000
CY2022Q1 lmfa Impairment Gain Loss On Digital Assets
ImpairmentGainLossOnDigitalAssets
0
CY2022Q1 lmfa Digital Assets Net Current
DigitalAssetsNetCurrent
504000

Files In Submission

Name View Source Status
0001564590-22-020441-index-headers.html Edgar Link pending
0001564590-22-020441-index.html Edgar Link pending
0001564590-22-020441.txt Edgar Link pending
0001564590-22-020441-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lmfa-10q_20220331.htm Edgar Link pending
lmfa-10q_20220331_htm.xml Edgar Link completed
lmfa-20220331.xsd Edgar Link pending
lmfa-20220331_cal.xml Edgar Link unprocessable
lmfa-20220331_def.xml Edgar Link unprocessable
lmfa-20220331_lab.xml Edgar Link unprocessable
lmfa-20220331_pre.xml Edgar Link unprocessable
lmfa-ex101_149.htm Edgar Link pending
lmfa-ex311_8.htm Edgar Link pending
lmfa-ex312_6.htm Edgar Link pending
lmfa-ex321_7.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending